These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A simple tool for monitoring nebulized amikacin treatments based on a single urine assay. Faurisson F; Delatour F; Jelazko P J Aerosol Med; 2001; 14(1):73-81. PubMed ID: 11495488 [TBL] [Abstract][Full Text] [Related]
3. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer]. Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418 [TBL] [Abstract][Full Text] [Related]
4. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Coates AL; Allen PD; MacNeish CF; Ho SL; Lands LC Chest; 2001 Apr; 119(4):1123-30. PubMed ID: 11296179 [TBL] [Abstract][Full Text] [Related]
5. Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients. Köhler E; Sollich V; Schuster-Wonka R; Jorch G J Aerosol Med; 2005; 18(4):386-95. PubMed ID: 16379615 [TBL] [Abstract][Full Text] [Related]
6. Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin. Reychler G; Leal T; Roeseler J; Thys F; Delvau N; Liistro G Respir Med; 2007 Oct; 101(10):2051-5. PubMed ID: 17628465 [TBL] [Abstract][Full Text] [Related]
7. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis. Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary Drug Delivery Following Continuous Vibrating Mesh Nebulization and Inspiratory Synchronized Vibrating Mesh Nebulization During Noninvasive Ventilation in Healthy Volunteers. Michotte JB; Staderini E; Aubriot AS; Jossen E; Dugernier J; Liistro G; Reychler G J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):33-41. PubMed ID: 28683216 [TBL] [Abstract][Full Text] [Related]
9. Aerosol delivery to the lung is more efficient using an extension with a standard jet nebulizer than an open-vent jet nebulizer. Pitance L; Reychler G; Leal T; Reychler H; Liistro G; Montharu J; Lab T; Diot P; Vecellio L J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):208-14. PubMed ID: 23286829 [TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI. Griese M; Eismann C; Börner G; Denk O; Schierholz JM; Keller M; Mazurek H; Kappler M J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):185-92. PubMed ID: 23789705 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary deposition of inhaled tobramycin prior to and after respiratory therapy and use of inhaled albuterol in cystic fibrosis patients colonized with Pseudomonas aeruginosa. Grotta MB; Etchebere EC; Ribeiro AF; Romanato J; Ribeiro MA; Ribeiro JD J Bras Pneumol; 2009 Jan; 35(1):35-43. PubMed ID: 19219329 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317 [TBL] [Abstract][Full Text] [Related]
13. Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. Pitance L; Vecellio L; Leal T; Reychler G; Reychler H; Liistro G J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):389-96. PubMed ID: 20958144 [TBL] [Abstract][Full Text] [Related]
14. Does wearing a noseclip during inhalation improve lung deposition? Köhler E; Sollich V; Schuster-Wonka R; Hühnerbein J; Jorch G J Aerosol Med; 2004; 17(2):116-22. PubMed ID: 15294061 [TBL] [Abstract][Full Text] [Related]
15. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin. Ehsan Z; Clancy JP Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178 [TBL] [Abstract][Full Text] [Related]
16. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer. Köhler E; Sollich V; Schuster-Wonka R; Hühnerbein J J Aerosol Med; 2003; 16(1):37-46. PubMed ID: 12737683 [TBL] [Abstract][Full Text] [Related]
17. Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways. Noone PG; Regnis JA; Liu X; Brouwer KL; Robinson M; Edwards L; Knowles MR Chest; 1997 Nov; 112(5):1283-90. PubMed ID: 9367469 [TBL] [Abstract][Full Text] [Related]
18. Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition. Coates AL; Dinh L; MacNeish CF; Rollin T; Gagnon S; Ho SL; Lands LC J Aerosol Med; 2000; 13(3):169-78. PubMed ID: 11066020 [TBL] [Abstract][Full Text] [Related]
19. Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. Reychler G; Wallemacq P; Rodenstein DO; Cumps J; Leal T; Liistro G J Aerosol Med; 2006; 19(2):199-207. PubMed ID: 16796544 [TBL] [Abstract][Full Text] [Related]
20. RhDNase I aerosol deposition and related factors in cystic fibrosis. Diot P; Palmer LB; Smaldone A; DeCelie-Germana J; Grimson R; Smaldone GC Am J Respir Crit Care Med; 1997 Nov; 156(5):1662-8. PubMed ID: 9372691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]